Population
2 familial hypertrophic cardiomyopathy patients carrying an Asp175Asn alpha-fast tropomyosin mutation and 2…
Comparison
Asp175Asn alpha-fast TM mutation vs Healthy control subjects lacking the mutant TM
Design
Preclinical
Authors
Loading...
Challenges hypothesis of primary contractile impairment in FHC; leaves open clinical relevance from animal data.
The Asp175Asn alpha-fast TM mutation is expressed in vivo and increases calcium sensitivity, challenging the hypothesis that FHC mutations primarily induce contractile impairment.
Bottinelli et al. (1998) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: